BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu XQ, Graichen R, Soo SY, Balakrishnan T, Rahmat SN, Sieh S, Tham SC, Freund C, Moore J, Mummery C. Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation. 2008;76:958-970. [PMID: 18557764 DOI: 10.1111/j.1432-0436.2008.00284.x] [Cited by in Crossref: 143] [Cited by in F6Publishing: 119] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Kensah G, Gruh I, Viering J, Schumann H, Dahlmann J, Meyer H, Skvorc D, Bär A, Akhyari P, Heisterkamp A, Haverich A, Martin U. A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation. Tissue Eng Part C Methods 2011;17:463-73. [PMID: 21142417 DOI: 10.1089/ten.TEC.2010.0405] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 7.5] [Reference Citation Analysis]
2 Lecina M, Ting S, Choo A, Reuveny S, Oh S. Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng Part C Methods. 2010;16:1609-1619. [PMID: 20590381 DOI: 10.1089/ten.tec.2010.0104] [Cited by in Crossref: 98] [Cited by in F6Publishing: 79] [Article Influence: 8.9] [Reference Citation Analysis]
3 Mehta A, Ramachandra CJ, Sequiera GL, Sudibyo Y, Nandihalli M, Yong PJ, Koh CH, Shim W. Phasic modulation of Wnt signaling enhances cardiac differentiation in human pluripotent stem cells by recapitulating developmental ontogeny. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2014;1843:2394-402. [DOI: 10.1016/j.bbamcr.2014.06.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
4 Uosaki H, Andersen P, Shenje LT, Fernandez L, Christiansen SL, Kwon C. Direct contact with endoderm-like cells efficiently induces cardiac progenitors from mouse and human pluripotent stem cells. PLoS One 2012;7:e46413. [PMID: 23056302 DOI: 10.1371/journal.pone.0046413] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
5 Bernstein HS, Hyun WC. Strategies for enrichment and selection of stem cell-derived tissue precursors. Stem Cell Res Ther 2012;3:17. [PMID: 22575029 DOI: 10.1186/scrt108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
6 Mummery CL, Zhang J, Ng ES, Elliott DA, Elefanty AG, Kamp TJ. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res. 2012;111:344-358. [PMID: 22821908 DOI: 10.1161/CIRCRESAHA.110.227512] [Cited by in Crossref: 438] [Cited by in F6Publishing: 236] [Article Influence: 48.7] [Reference Citation Analysis]
7 Engels MC, Rajarajan K, Feistritzer R, Sharma A, Nielsen UB, Schalij MJ, de Vries AA, Pijnappels DA, Wu SM. Insulin-like growth factor promotes cardiac lineage induction in vitro by selective expansion of early mesoderm. Stem Cells 2014;32:1493-502. [PMID: 24496962 DOI: 10.1002/stem.1660] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
8 Oh SK, Chen AK, Mok Y, Chen X, Lim U, Chin A, Choo AB, Reuveny S. Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Research 2009;2:219-30. [DOI: 10.1016/j.scr.2009.02.005] [Cited by in Crossref: 180] [Cited by in F6Publishing: 149] [Article Influence: 15.0] [Reference Citation Analysis]
9 Selga E, Sendfeld F, Martinez-Moreno R, Medine CN, Tura-Ceide O, Wilmut SI, Pérez GJ, Scornik FS, Brugada R, Mills NL. Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient. J Mol Cell Cardiol 2018;114:10-9. [PMID: 29024690 DOI: 10.1016/j.yjmcc.2017.10.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
10 Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 2010;90:1507-46. [PMID: 20959622 DOI: 10.1152/physrev.00054.2009] [Cited by in Crossref: 448] [Cited by in F6Publishing: 412] [Article Influence: 40.7] [Reference Citation Analysis]
11 Yang C, Al-Aama J, Stojkovic M, Keavney B, Trafford A, Lako M, Armstrong L. Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells. Stem Cells. 2015;33:2643-2651. [PMID: 26033645 DOI: 10.1002/stem.2070] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
12 Pal R. Embryonic stem (ES) cell-derived cardiomyocytes: A good candidate for cell therapy applications. Cell Biology International 2009;33:325-36. [DOI: 10.1016/j.cellbi.2008.12.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
13 Kempf H, Andree B, Zweigerdt R. Large-scale production of human pluripotent stem cell derived cardiomyocytes. Adv Drug Deliv Rev 2016;96:18-30. [PMID: 26658242 DOI: 10.1016/j.addr.2015.11.016] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 11.8] [Reference Citation Analysis]
14 Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, Hsiao C, Kamp TJ, Palecek SP. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat Protoc 2013;8:162-75. [PMID: 23257984 DOI: 10.1038/nprot.2012.150] [Cited by in Crossref: 783] [Cited by in F6Publishing: 681] [Article Influence: 87.0] [Reference Citation Analysis]
15 Son MY, Kim MJ, Yu K, Koo DB, Cho YS. Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells. J Cell Mol Med. 2011;15:152-165. [PMID: 19874423 DOI: 10.1111/j.1582-4934.2009.00956.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
16 Low JL, Jürjens G, Seayad J, Seow J, Ting S, Laco F, Reuveny S, Oh S, Chai CL. Tri-substituted imidazole analogues of SB203580 as inducers for cardiomyogenesis of human embryonic stem cells. Bioorg Med Chem Lett 2013;23:3300-3. [PMID: 23602399 DOI: 10.1016/j.bmcl.2013.03.103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
17 Talkhabi M, Aghdami N, Baharvand H. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art. Life Sci. 2016;145:98-113. [PMID: 26682938 DOI: 10.1016/j.lfs.2015.12.023] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
18 Zhu M, Zhao J, Chen G, Guan L. Early embryonic sensitivity to cyclophosphamide in cardiac differentiation from human embryonic stem cells. Cell Biol Int 2011;35:927-38. [DOI: 10.1042/cbi20110031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
19 Wei H, Zhang G, Qiu S, Lu J, Sheng J, Manasi, Tan G, Wong P, Gan SU, Shim W. Hydrogen sulfide suppresses outward rectifier potassium currents in human pluripotent stem cell-derived cardiomyocytes. PLoS One 2012;7:e50641. [PMID: 23226343 DOI: 10.1371/journal.pone.0050641] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
20 Chin AC, Padmanabhan J, Oh SK, Choo AB. Defined and serum-free media support undifferentiated human embryonic stem cell growth. Stem Cells Dev 2010;19:753-61. [PMID: 19686051 DOI: 10.1089/scd.2009.0210] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
21 Poon KL, Tan KT, Wei YY, Ng CP, Colman A, Korzh V, Xu XQ. RNA-binding protein RBM24 is required for sarcomere assembly and heart contractility. Cardiovascular Research 2012;94:418-27. [DOI: 10.1093/cvr/cvs095] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 7.4] [Reference Citation Analysis]
22 Lei IL, Bu L, Wang Z. Derivation of cardiac progenitor cells from embryonic stem cells. J Vis Exp 2015;:52047. [PMID: 25650840 DOI: 10.3791/52047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
23 Atkinson SP, Lako M, Armstrong L. Potential for pharmacological manipulation of human embryonic stem cells. Br J Pharmacol 2013;169:269-89. [PMID: 22515554 DOI: 10.1111/j.1476-5381.2012.01978.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
24 Takei S, Ichikawa H, Johkura K, Mogi A, No H, Yoshie S, Tomotsune D, Sasaki K. Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development. Am J Physiol Heart Circ Physiol 2009;296:H1793-803. [PMID: 19363129 DOI: 10.1152/ajpheart.01288.2008] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
25 Laflamme MA, Murry CE. Heart regeneration. Nature. 2011;473:326-335. [PMID: 21593865 DOI: 10.1038/nature10147] [Cited by in Crossref: 796] [Cited by in F6Publishing: 692] [Article Influence: 79.6] [Reference Citation Analysis]
26 Poon E, Kong CW, Li RA. Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective. Mol Pharm 2011;8:1495-504. [PMID: 21879736 DOI: 10.1021/mp2002363] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
27 Zweigerdt R. Large scale production of stem cells and their derivatives. Adv Biochem Eng Biotechnol 2009;114:201-35. [PMID: 19513633 DOI: 10.1007/10_2008_27] [Cited by in Crossref: 12] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
28 Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, Mahairaki V, Koliatsos VE, Tung L, Zambidis ET. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One. 2011;6:e18293. [PMID: 21494607 DOI: 10.1371/journal.pone.0018293] [Cited by in Crossref: 286] [Cited by in F6Publishing: 253] [Article Influence: 28.6] [Reference Citation Analysis]
29 Lian X, Xu J, Li J, Chien KR. Next-generation models of human cardiogenesis via genome editing. Cold Spring Harb Perspect Med 2014;4:a013920. [PMID: 25237142 DOI: 10.1101/cshperspect.a013920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
30 Zhang XZ. Modulation of embryonic stem cell fate and somatic cell reprogramming by small molecules. Reprod Biomed Online 2010;21:26-36. [PMID: 20462797 DOI: 10.1016/j.rbmo.2010.03.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
31 Pawani H, Nagvenkar P, Pethe P, Bhartiya D. Differentiation of human ES cell line KIND-2 to yield tripotent cardiovascular progenitors. In Vitro Cell Dev Biol Anim 2013;49:82-93. [PMID: 23288411 DOI: 10.1007/s11626-012-9558-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
32 Bouchard F, Paquin J. Differential effects of retinoids and inhibitors of ERK and p38 signaling on adipogenic and myogenic differentiation of P19 stem cells. Stem Cells Dev 2013;22:2003-16. [PMID: 23441952 DOI: 10.1089/scd.2012.0209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
33 Xu XQ, Sun W. Perspective from the heart: the potential of human pluripotent stem cell-derived cardiomyocytes. J Cell Biochem 2013;114:39-46. [PMID: 22903726 DOI: 10.1002/jcb.24359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
34 Rajala K, Pekkanen-Mattila M, Aalto-Setälä K. Cardiac differentiation of pluripotent stem cells. Stem Cells Int 2011;2011:383709. [PMID: 21603143 DOI: 10.4061/2011/383709] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 7.2] [Reference Citation Analysis]
35 Riebeling C, Schlechter K, Buesen R, Spielmann H, Luch A, Seiler A. Defined culture medium for stem cell differentiation: applicability of serum-free conditions in the mouse embryonic stem cell test. Toxicol In Vitro 2011;25:914-21. [PMID: 21376803 DOI: 10.1016/j.tiv.2011.02.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
36 Pesl M, Acimovic I, Pribyl J, Hezova R, Vilotic A, Fauconnier J, Vrbsky J, Kruzliak P, Skladal P, Kara T. Forced aggregation and defined factors allow highly uniform-sized embryoid bodies and functional cardiomyocytes from human embryonic and induced pluripotent stem cells. Heart Vessels. 2014;29:834-846. [PMID: 24258387 DOI: 10.1007/s00380-013-0436-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
37 Hudson J, Titmarsh D, Hidalgo A, Wolvetang E, Cooper-White J. Primitive cardiac cells from human embryonic stem cells. Stem Cells Dev 2012;21:1513-23. [PMID: 21933026 DOI: 10.1089/scd.2011.0254] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 6.0] [Reference Citation Analysis]
38 Feric NT, Radisic M. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv Drug Deliv Rev 2016;96:110-34. [PMID: 25956564 DOI: 10.1016/j.addr.2015.04.019] [Cited by in Crossref: 121] [Cited by in F6Publishing: 102] [Article Influence: 20.2] [Reference Citation Analysis]
39 Gong R, Jiang Z, Zagidullin N, Liu T, Cai B. Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration. Signal Transduct Target Ther 2021;6:31. [PMID: 33500391 DOI: 10.1038/s41392-020-00413-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Rust W, Balakrishnan T, Zweigerdt R. Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression. Regen Med. 2009;4:225-237. [PMID: 19317642 DOI: 10.2217/17460751.4.2.225] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
41 Schade D, Plowright AT. Medicinal Chemistry Approaches to Heart Regeneration. J Med Chem 2015;58:9451-79. [DOI: 10.1021/acs.jmedchem.5b00446] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
42 Brenner C, Franz WM. The use of stem cells for the repair of cardiac tissue in ischemic heart disease. Expert Rev Med Devices 2011;8:209-25. [PMID: 21381911 DOI: 10.1586/erd.10.78] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
43 Abou-Saleh H, Zouein FA, El-Yazbi A, Sanoudou D, Raynaud C, Rao C, Pintus G, Dehaini H, Eid AH. The march of pluripotent stem cells in cardiovascular regenerative medicine. Stem Cell Res Ther 2018;9:201. [PMID: 30053890 DOI: 10.1186/s13287-018-0947-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
44 Kempf H, Zweigerdt R. Scalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small Molecules. Adv Biochem Eng Biotechnol 2018;163:39-69. [PMID: 29071404 DOI: 10.1007/10_2017_30] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
45 Jara-Avaca M, Kempf H, Rückert M, Robles-Diaz D, Franke A, de la Roche J, Fischer M, Malan D, Sasse P, Solodenko W, Dräger G, Kirschning A, Martin U, Zweigerdt R. EBIO Does Not Induce Cardiomyogenesis in Human Pluripotent Stem Cells but Modulates Cardiac Subtype Enrichment by Lineage-Selective Survival. Stem Cell Reports 2017;8:305-17. [PMID: 28089668 DOI: 10.1016/j.stemcr.2016.12.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
46 Magdy T, Schuldt AJT, Wu JC, Bernstein D, Burridge PW. Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems. Annu Rev Pharmacol Toxicol. 2018;58:83-103. [PMID: 28992430 DOI: 10.1146/annurev-pharmtox-010617-053110] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 14.0] [Reference Citation Analysis]
47 Kempf H, Lecina M, Ting S, Zweigerdt R, Oh S. Distinct regulation of mitogen-activated protein kinase activities is coupled with enhanced cardiac differentiation of human embryonic stem cells. Stem Cell Res. 2011;7:198-209. [PMID: 21907163 DOI: 10.1016/j.scr.2011.06.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
48 Hartung S, Schwanke K, Haase A, David R, Franz WM, Martin U, Zweigerdt R. Directing cardiomyogenic differentiation of human pluripotent stem cells by plasmid-based transient overexpression of cardiac transcription factors. Stem Cells Dev 2013;22:1112-25. [PMID: 23157212 DOI: 10.1089/scd.2012.0351] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
49 Jiang B, Yan L, Shamul JG, Hakun M, He X. Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering. Adv Ther (Weinh) 2020;3:1900182. [PMID: 33665356 DOI: 10.1002/adtp.201900182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
50 Ackermann M, Lachmann N, Hartung S, Eggenschwiler R, Pfaff N, Happle C, Mucci A, Göhring G, Niemann H, Hansen G, Schambach A, Cantz T, Zweigerdt R, Moritz T. Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy. Biomaterials 2014;35:1531-42. [PMID: 24290698 DOI: 10.1016/j.biomaterials.2013.11.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
51 Yook J, Kim M, Son MJ, Lee S, Nam Y, Han Y, Cho YS. Combinatorial Activin Receptor-Like Kinase/Smad and Basic Fibroblast Growth Factor Signals Stimulate the Differentiation of Human Embryonic Stem Cells into the Cardiac Lineage. Stem Cells and Development 2011;20:1479-90. [DOI: 10.1089/scd.2010.0392] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
52 Liu BH, Yeh HY, Lin YC, Wang MH, Chen DC, Lee BH, Hsu SH. Spheroid formation and enhanced cardiomyogenic potential of adipose-derived stem cells grown on chitosan. Biores Open Access 2013;2:28-39. [PMID: 23514754 DOI: 10.1089/biores.2012.0285] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
53 Ting S, Lecina M, Reuveny S, Oh S. Differentiation of human embryonic stem cells to cardiomyocytes on microcarrier cultures. Curr Protoc Stem Cell Biol. 2012;Chapter 1:Unit1D.7. [PMID: 22605644 DOI: 10.1002/9780470151808.sc01d07s21] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
54 Akhmedov AT, Marín-García J. Myocardial regeneration of the failing heart. Heart Fail Rev 2013;18:815-33. [PMID: 23001638 DOI: 10.1007/s10741-012-9348-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
55 Furth ME, Atala A. Tissue Engineering. Principles of Tissue Engineering. Elsevier; 2014. pp. 83-123. [DOI: 10.1016/b978-0-12-398358-9.00006-9] [Cited by in Crossref: 11] [Article Influence: 1.6] [Reference Citation Analysis]
56 Schwanke K, Merkert S, Kempf H, Hartung S, Jara-Avaca M, Templin C, Göhring G, Haverich A, Martin U, Zweigerdt R. Fast and efficient multitransgenic modification of human pluripotent stem cells. Hum Gene Ther Methods 2014;25:136-53. [PMID: 24483184 DOI: 10.1089/hgtb.2012.248] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
57 Ho P, Yen M, Yet S, Yen BL. Current Applications of Human Pluripotent Stem Cells: Possibilities and Challenges. Cell Transplant 2012;21:801-14. [DOI: 10.3727/096368911x627507] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
58 Liu J, Zhang Z, Liu Y, Guo C, Gong Y, Yang S, Ma M, Li Z, Gao WQ, He Z. Generation, characterization, and potential therapeutic applications of cardiomyocytes from various stem cells. Stem Cells Dev 2012;21:2095-110. [PMID: 22428725 DOI: 10.1089/scd.2012.0031] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
59 Burridge PW, Keller G, Gold JD, Wu JC. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell. 2012;10:16-28. [PMID: 22226352 DOI: 10.1016/j.stem.2011.12.013] [Cited by in Crossref: 438] [Cited by in F6Publishing: 377] [Article Influence: 48.7] [Reference Citation Analysis]
60 Nijmeijer RM, Leeuwis JW, DeLisio A, Mummery CL, Chuva de Sousa Lopes SM. Visceral endoderm induces specification of cardiomyocytes in mice. Stem Cell Res 2009;3:170-8. [PMID: 19631601 DOI: 10.1016/j.scr.2009.06.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
61 Zhang M, Schulte JS, Heinick A, Piccini I, Rao J, Quaranta R, Zeuschner D, Malan D, Kim KP, Röpke A, Sasse P, Araúzo-Bravo M, Seebohm G, Schöler H, Fabritz L, Kirchhof P, Müller FU, Greber B. Universal cardiac induction of human pluripotent stem cells in two and three-dimensional formats: implications for in vitro maturation. Stem Cells 2015;33:1456-69. [PMID: 25639979 DOI: 10.1002/stem.1964] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 11.4] [Reference Citation Analysis]
62 Le MNT, Takahi M, Maruyama K, Kurisaki A, Ohnuma K. Cardiac differentiation at an initial low density of human-induced pluripotent stem cells. In Vitro Cell Dev Biol Anim 2018;54:513-22. [PMID: 29967976 DOI: 10.1007/s11626-018-0276-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
63 Jin G, Palecek SP. Inductive factors for generation of pluripotent stem cell-derived cardiomyocytes. Engineering Strategies for Regenerative Medicine. Elsevier; 2020. pp. 177-242. [DOI: 10.1016/b978-0-12-816221-7.00006-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Shinde V, Klima S, Sureshkumar PS, Meganathan K, Jagtap S, Rempel E, Rahnenführer J, Hengstler JG, Waldmann T, Hescheler J, Leist M, Sachinidis A. Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation. J Vis Exp 2015;:e52333. [PMID: 26132533 DOI: 10.3791/52333] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
65 Kensah G, Roa Lara A, Dahlmann J, Zweigerdt R, Schwanke K, Hegermann J, Skvorc D, Gawol A, Azizian A, Wagner S, Maier LS, Krause A, Dräger G, Ochs M, Haverich A, Gruh I, Martin U. Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. Eur Heart J 2013;34:1134-46. [PMID: 23103664 DOI: 10.1093/eurheartj/ehs349] [Cited by in Crossref: 133] [Cited by in F6Publishing: 116] [Article Influence: 14.8] [Reference Citation Analysis]
66 Jara Avaca M, Gruh I. Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application. Adv Biochem Eng Biotechnol. 2018;163:117-146. [PMID: 29218360 DOI: 10.1007/10_2017_24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Bernstein HS. Cardiac repair and restoration using human embryonic stem cells. Regenerative Medicine 2012;7:697-712. [DOI: 10.2217/rme.12.46] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
68 Acimovic I, Vilotic A, Pesl M, Lacampagne A, Dvorak P, Rotrekl V, Meli AC. Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. Biomed Res Int 2014;2014:512831. [PMID: 24800237 DOI: 10.1155/2014/512831] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
69 Zhang F, Zhu Y, Chen J, Kuang W, Huang R, Duan F, Li Y, Wang L, Qiu H, Chen X, Ming J, Liu P, Du Y, Chang SC, Chen L, Na J. Efficient endothelial and smooth muscle cell differentiation from human pluripotent stem cells through a simplified insulin-free culture system. Biomaterials 2021;271:120713. [PMID: 33618219 DOI: 10.1016/j.biomaterials.2021.120713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Jones MB, Chu CH, Pendleton JC, Betenbaugh MJ, Shiloach J, Baljinnyam B, Rubin JS, Shamblott MJ. Proliferation and pluripotency of human embryonic stem cells maintained on type I collagen. Stem Cells Dev 2010;19:1923-35. [PMID: 20367282 DOI: 10.1089/scd.2009.0326] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
71 Savla JJ, Nelson BC, Perry CN, Adler ED. Induced Pluripotent Stem Cells for the Study of Cardiovascular Disease. Journal of the American College of Cardiology 2014;64:512-9. [DOI: 10.1016/j.jacc.2014.05.038] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
72 Weber N, Schwanke K, Greten S, Wendland M, Iorga B, Fischer M, Geers-Knörr C, Hegermann J, Wrede C, Fiedler J, Kempf H, Franke A, Piep B, Pfanne A, Thum T, Martin U, Brenner B, Zweigerdt R, Kraft T. Stiff matrix induces switch to pure β-cardiac myosin heavy chain expression in human ESC-derived cardiomyocytes. Basic Res Cardiol 2016;111:68. [PMID: 27743117 DOI: 10.1007/s00395-016-0587-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 7.4] [Reference Citation Analysis]
73 Ting S, Lecina M, Chan YC, Tse HF, Reuveny S, Oh SK. Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells. World J Stem Cells 2013;5:86-97. [PMID: 23904910 DOI: 10.4252/wjsc.v5.i3.86] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
74 Zhang GQ, Wei H, Lu J, Wong P, Shim W. Identification and characterization of calcium sparks in cardiomyocytes derived from human induced pluripotent stem cells. PLoS One 2013;8:e55266. [PMID: 23408964 DOI: 10.1371/journal.pone.0055266] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
75 Pekkanen-Mattila M, Pelto-Huikko M, Kujala V, Suuronen R, Skottman H, Aalto-Setälä K, Kerkelä E. Spatial and temporal expression pattern of germ layer markers during human embryonic stem cell differentiation in embryoid bodies. Histochem Cell Biol 2010;133:595-606. [PMID: 20369364 DOI: 10.1007/s00418-010-0689-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
76 Sison-young R, Kia R, Heslop J, Kelly L, Rowe C, Cross M, Kitteringham N, Hanley N, Park B, Goldring C. Human Pluripotent Stem Cells for Modeling Toxicity. Current Concepts in Drug Metabolism and Toxicology. Elsevier; 2012. pp. 207-56. [DOI: 10.1016/b978-0-12-398339-8.00006-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
77 Haraguchi Y, Shimizu T, Yamato M, Okano T. Concise review: cell therapy and tissue engineering for cardiovascular disease. Stem Cells Transl Med 2012;1:136-41. [PMID: 23197760 DOI: 10.5966/sctm.2012-0030] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
78 Xu XQ, Soo SY, Sun W, Zweigerdt R. Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells. Stem Cells 2009;27:2163-74. [PMID: 19658189 DOI: 10.1002/stem.166] [Cited by in Crossref: 114] [Cited by in F6Publishing: 105] [Article Influence: 9.5] [Reference Citation Analysis]
79 Gupta MK, Illich DJ, Gaarz A, Matzkies M, Nguemo F, Pfannkuche K, Liang H, Classen S, Reppel M, Schultze JL, Hescheler J, Sarić T. Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar. BMC Dev Biol 2010;10:98. [PMID: 20843318 DOI: 10.1186/1471-213X-10-98] [Cited by in Crossref: 57] [Cited by in F6Publishing: 40] [Article Influence: 5.2] [Reference Citation Analysis]
80 Lewandowski J, Kolanowski TJ, Kurpisz M. Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes. J Tissue Eng Regen Med 2017;11:1658-74. [PMID: 26777594 DOI: 10.1002/term.2117] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
81 David R, Jarsch VB, Schwarz F, Nathan P, Gegg M, Lickert H, Franz WM. Induction of MesP1 by Brachyury(T) generates the common multipotent cardiovascular stem cell. Cardiovasc Res 2011;92:115-22. [PMID: 21632880 DOI: 10.1093/cvr/cvr158] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 5.2] [Reference Citation Analysis]
82 Martins AM, Vunjak-Novakovic G, Reis RL. The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine. Stem Cell Rev Rep 2014;10:177-90. [PMID: 24425421 DOI: 10.1007/s12015-013-9487-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 5.9] [Reference Citation Analysis]
83 Evans T. Embryonic Stem Cells as a Model for Cardiac Development and Disease. Drug Discov Today Dis Models 2008;5:147-55. [PMID: 19802368 DOI: 10.1016/j.ddmod.2009.03.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
84 Sirabella D, Cimetta E, Vunjak-Novakovic G. "The state of the heart": Recent advances in engineering human cardiac tissue from pluripotent stem cells. Exp Biol Med (Maywood) 2015;240:1008-18. [PMID: 26069271 DOI: 10.1177/1535370215589910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
85 Habib M, Caspi O, Gepstein L. Human embryonic stem cells for cardiomyogenesis. J Mol Cell Cardiol 2008;45:462-74. [PMID: 18775434 DOI: 10.1016/j.yjmcc.2008.08.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
86 Xu C. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells. J Mol Cell Cardiol. 2012;52:1203-1212. [PMID: 22484618 DOI: 10.1016/j.yjmcc.2012.03.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
87 Massai D, Bolesani E, Diaz DR, Kropp C, Kempf H, Halloin C, Martin U, Braniste T, Isu G, Harms V, Morbiducci U, Dräger G, Zweigerdt R. Sensitivity of human pluripotent stem cells to insulin precipitation induced by peristaltic pump-based medium circulation: considerations on process development. Sci Rep 2017;7:3950. [PMID: 28638147 DOI: 10.1038/s41598-017-04158-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
88 Lescroart F, Meilhac SM. Cell lineages, growth and repair of the mouse heart. Results Probl Cell Differ 2012;55:263-89. [PMID: 22918812 DOI: 10.1007/978-3-642-30406-4_15] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
89 Xiong JW, Chang NN. Recent advances in heart regeneration. Birth Defects Res C Embryo Today 2013;99:160-9. [PMID: 24078494 DOI: 10.1002/bdrc.21039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
90 Baddour JA, Sousounis K, Tsonis PA. Organ repair and regeneration: An overview. Birth Defects Research Part C: Embryo Today: Reviews 2012;96:1-29. [DOI: 10.1002/bdrc.21006] [Cited by in Crossref: 82] [Cited by in F6Publishing: 63] [Article Influence: 9.1] [Reference Citation Analysis]
91 Wong SS, Bernstein HS. Cardiac regeneration using human embryonic stem cells: producing cells for future therapy. Regen Med 2010;5:763-75. [PMID: 20868331 DOI: 10.2217/rme.10.52] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
92 Gao M, Yang J, Wei R, Liu G, Zhang L, Wang H, Wang G, Gao H, Chen G, Hong T. Ghrelin induces cardiac lineage differentiation of human embryonic stem cells through ERK1/2 pathway. Int J Cardiol 2013;167:2724-33. [PMID: 22809535 DOI: 10.1016/j.ijcard.2012.06.106] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
93 Phillips BW, Crook JM. Pluripotent Human Stem Cells: A Novel Tool in Drug Discovery. BioDrugs 2010;24:99-108. [DOI: 10.2165/11532270-000000000-00000] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
94 Keung W, Boheler KR, Li RA. Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther 2014;5:17. [PMID: 24467782 DOI: 10.1186/scrt406] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 8.4] [Reference Citation Analysis]
95 Lian X, Zhang J, Zhu K, Kamp TJ, Palecek SP. Insulin inhibits cardiac mesoderm, not mesendoderm, formation during cardiac differentiation of human pluripotent stem cells and modulation of canonical Wnt signaling can rescue this inhibition. Stem Cells 2013;31:447-57. [PMID: 23193013 DOI: 10.1002/stem.1289] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
96 Kotasová H, Veselá I, Kučera J, Houdek Z, Procházková J, Králičková M, Pacherník J. Phosphoinositide 3-kinase inhibition enables retinoic acid-induced neurogenesis in monolayer culture of embryonic stem cells. J Cell Biochem 2012;113:563-70. [PMID: 21948563 DOI: 10.1002/jcb.23380] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
97 Bieberich E. It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation. Neurochem Res 2012;37:1208-29. [PMID: 22246226 DOI: 10.1007/s11064-011-0698-5] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 8.2] [Reference Citation Analysis]
98 Olmer R, Martin U. Induced Pluripotent Stem Cells Differentiate into Functional Cardiomyocytes. In: Hayat M, editor. Stem Cells and Cancer Stem Cells, Volume 12. Dordrecht: Springer Netherlands; 2014. pp. 47-62. [DOI: 10.1007/978-94-017-8032-2_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
99 Lodrini AM, Barile L, Rocchetti M, Altomare C. Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform. Int J Mol Sci 2020;21:E507. [PMID: 31941149 DOI: 10.3390/ijms21020507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
100 Jha R, Xu RH, Xu C. Efficient differentiation of cardiomyocytes from human pluripotent stem cells with growth factors. Methods Mol Biol 2015;1299:115-31. [PMID: 25836579 DOI: 10.1007/978-1-4939-2572-8_9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
101 Braam SR, Passier R, Mummery CL. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Trends Pharmacol Sci 2009;30:536-45. [PMID: 19762090 DOI: 10.1016/j.tips.2009.07.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
102 Lam AT, Chen AK, Li J, Birch WR, Reuveny S, Oh SK. Conjoint propagation and differentiation of human embryonic stem cells to cardiomyocytes in a defined microcarrier spinner culture. Stem Cell Res Ther 2014;5:110. [PMID: 25223792 DOI: 10.1186/scrt498] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
103 Bauwens CL, Song H, Thavandiran N, Ungrin M, Massé S, Nanthakumar K, Seguin C, Zandstra PW. Geometric control of cardiomyogenic induction in human pluripotent stem cells. Tissue Eng Part A 2011;17:1901-9. [PMID: 21417693 DOI: 10.1089/ten.TEA.2010.0563] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
104 Konze SA, Werneburg S, Oberbeck A, Olmer R, Kempf H, Jara-avaca M, Pich A, Zweigerdt R, Buettner FFR. Proteomic Analysis of Human Pluripotent Stem Cell Cardiomyogenesis Revealed Altered Expression of Metabolic Enzymes and PDLIM5 Isoforms. J Proteome Res 2017;16:1133-49. [DOI: 10.1021/acs.jproteome.6b00534] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
105 Dierickx P, Doevendans PA, Geijsen N, van Laake LW. Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair. J Cardiovasc Transl Res 2012;5:566-80. [PMID: 22806916 DOI: 10.1007/s12265-012-9391-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
106 Pei F, Jiang J, Bai S, Cao H, Tian L, Zhao Y, Yang C, Dong H, Ma Y. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells. Stem Cell Res 2017;19:94-103. [PMID: 28110125 DOI: 10.1016/j.scr.2017.01.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 10.5] [Reference Citation Analysis]
107 Hao M, Wang R, Wang W. Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials. Anal Cell Pathol (Amst) 2017;2017:9404057. [PMID: 28194324 DOI: 10.1155/2017/9404057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
108 Wobus AM, Löser P. Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch Toxicol 2011;85:79-117. [PMID: 21225242 DOI: 10.1007/s00204-010-0641-6] [Cited by in Crossref: 105] [Cited by in F6Publishing: 74] [Article Influence: 10.5] [Reference Citation Analysis]
109 Singh H, Mok P, Balakrishnan T, Rahmat SNB, Zweigerdt R. Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Research 2010;4:165-79. [DOI: 10.1016/j.scr.2010.03.001] [Cited by in Crossref: 125] [Cited by in F6Publishing: 96] [Article Influence: 11.4] [Reference Citation Analysis]
110 Xu C, Police S, Hassanipour M, Li Y, Chen Y, Priest C, O’Sullivan C, Laflamme MA, Zhu WZ, Van Biber B. Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells. Regen Med. 2011;6:53-66. [PMID: 21175287 DOI: 10.2217/rme.10.91] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 6.7] [Reference Citation Analysis]
111 Konze SA, van Diepen L, Schröder A, Olmer R, Möller H, Pich A, Weißmann R, Kuss AW, Zweigerdt R, Buettner FF. Cleavage of E-cadherin and β-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cells. Mol Cell Proteomics 2014;13:990-1007. [PMID: 24482122 DOI: 10.1074/mcp.M113.033423] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
112 Braam SR, Nauw R, Ward-van Oostwaard D, Mummery C, Passier R. Inhibition of ROCK improves survival of human embryonic stem cell-derived cardiomyocytes after dissociation. Ann N Y Acad Sci 2010;1188:52-7. [PMID: 20201886 DOI: 10.1111/j.1749-6632.2009.05083.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
113 Schaaf S, Shibamiya A, Mewe M, Eder A, Stöhr A, Hirt MN, Rau T, Zimmermann WH, Conradi L, Eschenhagen T, Hansen A. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 2011;6:e26397. [PMID: 22028871 DOI: 10.1371/journal.pone.0026397] [Cited by in Crossref: 247] [Cited by in F6Publishing: 210] [Article Influence: 24.7] [Reference Citation Analysis]
114 Bernstein HS, Srivastava D. Stem cell therapy for cardiac disease. Pediatr Res 2012;71:491-9. [DOI: 10.1038/pr.2011.61] [Cited by in Crossref: 76] [Cited by in F6Publishing: 60] [Article Influence: 8.4] [Reference Citation Analysis]
115 Vidarsson H, Hyllner J, Sartipy P. Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications. Stem Cell Rev Rep 2010;6:108-20. [PMID: 20091143 DOI: 10.1007/s12015-010-9113-x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
116 Bellin M, Marchetto MC, Gage FH, Mummery CL. Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol. 2012;13:713-726. [PMID: 23034453 DOI: 10.1038/nrm3448] [Cited by in Crossref: 293] [Cited by in F6Publishing: 259] [Article Influence: 32.6] [Reference Citation Analysis]
117 Zhang T, Lin Y, Liu J, Zhang ZG, Fu W, Guo LY, Pan L, Kong X, Zhang MK, Lu YH, Huang ZR, Xie Q, Li WH, Xu XQ. Rbm24 Regulates Alternative Splicing Switch in Embryonic Stem Cell Cardiac Lineage Differentiation. Stem Cells 2016;34:1776-89. [PMID: 26990106 DOI: 10.1002/stem.2366] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
118 Stastna M, Van Eyk JE. Secreted proteins as a fundamental source for biomarker discovery. Proteomics 2012;12:722-35. [PMID: 22247067 DOI: 10.1002/pmic.201100346] [Cited by in Crossref: 112] [Cited by in F6Publishing: 91] [Article Influence: 12.4] [Reference Citation Analysis]
119 David R, Schwarz F, Rimmbach C, Nathan P, Jung J, Brenner C, Jarsch V, Stieber J, Franz W. Selection of a common multipotent cardiovascular stem cell using the 3.4-kb MesP1 promoter fragment. Basic Res Cardiol 2013;108. [DOI: 10.1007/s00395-012-0312-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]